Overview
Carsten Riether practices in Bern, Switzerland. Mr. Riether is rated as an Advanced expert by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Leukemia, Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), and Necrosis.
His clinical research consists of co-authoring 66 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 10 articles in the study of Chronic Myelogenous Leukemia (CML).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Mr. Riether isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Chronic Myelogenous Leukemia (CML)Mr. Riether isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- LeukemiaMr. Riether isAdvanced. Learn about Leukemia.
- Experienced
- Follicular LymphomaMr. Riether isExperienced. Learn about Follicular Lymphoma.
- Hypereosinophilic SyndromeMr. Riether isExperienced. Learn about Hypereosinophilic Syndrome.
- Lung CancerMr. Riether isExperienced. Learn about Lung Cancer.
- MelanomaMr. Riether isExperienced. Learn about Melanoma.
- NecrosisMr. Riether isExperienced. Learn about Necrosis.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Riether isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).